Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

WATERS CORPORATION

Waters Corp. designs, manufactures, sells and services ultra performance liquid chromatography (UPLC), high performan... read more Featured Products: More products

Download Mobile App




Protein Saliva Test Diagnoses Autism

By LabMedica International staff writers
Posted on 11 Feb 2015
Autism spectrum disorder (ASD) currently affects one in 68 US children, and the number of people diagnosed with autism continues to rise, and diagnosis is currently made based on behavioral observations, but no biological test for autism exists.

Recent developments in biochemistry technology could help facilitate study of ASD at the protein level, providing much-needed insights into causes and consequences and convergence of multiple genetic pathways to affect a few common protein biomarkers has been proposed. More...


Scientists at Clarkson University (Potsdam, NY, USA) collected human saliva samples at a neuropsychology clinic and participant identities were unknown to the investigators conducting the study. Participants, ages 5 to 17, either had ASD diagnosed or were control subjects without any ASD diagnosis or diagnosis of any other neurodevelopmental, psychiatric, or major medical condition. Saliva samples from six donors were analyzed twofold. In the first case, six individual saliva samples from six donors were pooled in one ASD sample (ASD pooled sample) and the same was done with the six control samples.

The samples were analyzed by a nanoliquid chromatography-tandem mass spectrometer (nanoLC-MS/MS) using a NanoAcquity UPLC (Waters Corp.; Milford, MA, USA) coupled to a Waters’ quadrupole-time-of-flight (QTOF) Micro MS through a 20 µm ID picotip emitter (New Objective, Woburn, MA, USA). Quantitation of differentially regulated proteins within each individual ASD and control samples was performed in two ways: precursor ion intensity and spectral counting.

The team found statistically significant differences in several salivary proteins, including elevated prolactin-inducible protein, lactotransferrin, immunoglobulin (Ig) kappa chain C region, Ig gamma-1 chain C region, Ig lambda-2 chain C regions, neutrophil elastase, polymeric immunoglobulin receptor and deleted in malignant brain tumors 1. The proteins identified primarily have functions in immune system responses, or are elevated in people with gastrointestinal problems. The group also reported that several of the identified proteins interact with one another.

Costel C. Darie, PhD, a co-lead author and proteomics expert said, “We are the first in the world who proposed a protein complex as a potential biomarker signature, which gives us information not only about the proteins, their relative quantities and their modifications, but also about their interactions with other proteins.” The work is promising for the eventual development of an autism diagnostic test although more subjects need to be studied to confirm that the markers are consistently different in people with autism. The study was published on January 27, 2015, in the journal Autism Research.

Related Links:

Clarkson University
Waters Corp.
New Objective



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Avantect Pancreatic Cancer Test combines epigenomic, genomic, and glycan biomarkers with machine learning to detect pancreatic cancer-associated signals in blood (Photo courtesy of ClearNote Health)

Multiomic Blood Test Supports Noninvasive Monitoring and Subtyping in Pancreatic Cancer

Pancreatic ductal adenocarcinoma remains difficult to detect early and monitor during treatment, particularly in patients with homologous recombination defects. Clinicians also have limited noninvasive... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image Credit: Adobe Stock

Mayo Clinic and Thermo Fisher Launch Multi-Omics Venture to Identify Early Disease Signals

Many diseases begin developing years before symptoms emerge, making early detection difficult for healthcare systems and clinical laboratories. Linking molecular changes with longitudinal health data could... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.